Taipei, Feb. 14 (CNA) A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Taiwan's weekly COVID-19 infections down 3%, mostly BA.5]()
Taiwan's weekly COVID-19 infections down 3%, mostly BA.5The number of COVID-19 infections in Taiwan dropped last week for the first time in over a month, falling by 3 percent from a week earlier, with cases caused by the BA.5 ...09/26/2022 06:37 PM![Taiwan reports 28,785 new COVID-19 cases, 56 deaths]()
Taiwan reports 28,785 new COVID-19 cases, 56 deathsTaiwan reported 28,785 new COVID-19 infections and 56 deaths from the disease Monday, according to the Central Epidemic Command Center (CECC).09/26/2022 04:04 PM![Next round of rapid test rationing plan to start Oct. 1]()
Next round of rapid test rationing plan to start Oct. 1The sixth round of the government's COVID-19 rapid test rationing scheme will begin on Oct. 1, with every holder of a national health insurance (NHI) card or Alien Residence ...09/26/2022 03:36 PM
Latest
- Politics
Former U.S. top diplomat Mike Pompeo arrives in Taiwan
09/26/2022 10:30 PM - Sports
HeroBears to face DEA in interleague basketball tournament final
09/26/2022 09:55 PM - Science & Tech
Jupiter to make closest approach to Earth in 59 years: Museum
09/26/2022 09:36 PM - Culture
Taipei museum to hold exhibition on Southeast Asian cultural relics
09/26/2022 09:32 PM - Business
Manufacturing business sentiment weakens to over 2-year low
09/26/2022 09:06 PM